NDC 15631-0027-07 - AMMONIUM CARBONICUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 15631-0027
- Requested NDC
- 15631-0027-07
- Package NDCs from labels
- 15631-0027-0, 15631-0027-1, 15631-0027-2, 15631-0027-3, 15631-0027-4, 15631-0027-5, 15631-0027-6, 15631-0027-7, 15631-0027-07
- Manufacturer
- Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
- Effective date
- 2021-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMMONIUM CARBONICUM - Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | 2021-10-08 | HUMAN OTC DRUG LABEL |
| Rxhomeo Homeopathic Combo 19 | Rxhomeo Private Limited d.b.a. | Rxhomeo Private Limited d.b.a.,Rxhomeo, Inc | 2016-10-24 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 15631-0027-0 | 2021-10-08 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-1 | 2021-10-08 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-2 | 2021-10-08 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-3 | 2021-10-08 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-4 | 2021-10-08 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-5 | 2021-10-08 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-0 | 2020-01-31 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-1 | 2020-01-31 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-2 | 2020-01-31 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-3 | 2020-01-31 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-4 | 2020-01-31 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
| 15631-0027-5 | 2020-01-31 | 4a812041-45e2-4f26-b0c7-670aa7cdcdb0 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 15631-0027-0 | AMMONIUM CARBONICUM | 100 in 1 PACKAGE | PELLET | 100 | 2 | |
| 15631-0027-1 | AMMONIUM CARBONICUM | 200 in 1 PACKAGE | PELLET | 200 | 2 | |
| 15631-0027-2 | AMMONIUM CARBONICUM | 400 in 1 PACKAGE | PELLET | 400 | 2 | |
| 15631-0027-3 | AMMONIUM CARBONICUM | 750 in 1 PACKAGE | PELLET | 750 | 2 | |
| 15631-0027-4 | AMMONIUM CARBONICUM | 2500 in 1 PACKAGE | PELLET | 2500 | 2 | |
| 15631-0027-5 | AMMONIUM CARBONICUM | 12500 in 1 PACKAGE | PELLET | 12500 | 2 | |
| 15631-0027-6 | AMMONIUM CARBONICUM | 500 in 1 PACKAGE | PELLET | 500 | 2 | |
| 15631-0027-7 | AMMONIUM CARBONICUM | 1000 in 1 PACKAGE | PELLET | 1000 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 15631-0027 | AMMONIUM CARBONICUM PELLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC] | 2 | Current NDC, Legacy NDC, 8 package rows | 20211009_4a812041-45e2-4f26-b0c7-670aa7cdcdb0.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMMONIUM CARBONATE | ACTIVE INGREDIENT | NJ5VT0FKLJ | AMMONIUM CARBONICUM PELLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC] | 1 | |
| AMMONIUM CATION | ACTIVE MOIETY | 54S68520I4 | AMMONIUM CARBONICUM PELLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC] | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | AMMONIUM CARBONICUM PELLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | ace1eb11-b925-405a-b772-58c60b3ca7d4 | 2026-09-09 | Warnings, Adverse reactions | 660YQ98I10 |
| BMNP AMMONIUM CARBONICUM | AMMONIUM CARBONICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a6a177e-3aca-b4aa-e063-6394a90afa28 | 2026-09-01 | Warnings | NJ5VT0FKLJ |
| BMNP Kali Mur | KALIUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a546950-3f03-7abf-e063-6294a90a1968 | 2026-08-31 | Warnings | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | 2c407aaf-5d95-49ff-a5db-f1d7b5190334 | 2026-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Electrolyte Plus | KALI MURIATICUM, L-ARGININE, L-CARNITINE, L-LEUCINE, L-ORNITHINE, L-VALINE, MAGNESIA MURIATICA, ASCORBICUM ACIDUM, BORAX, CHROMIUM OXYDATUM, FERRUM MURIATICUM, KALI CARBONICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NATRUM MURIATICUM, ZINCUM GLUCONICUM, CUPRUM METALLICUM, KALI PHOSPHORICUM, NICCOLUM METALLICUM, SELENIUM METALLICUM, VANADIUM METALLICUM, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, MANGANUM CARBONICUM | Deseret Biologicals, Inc. | e3564733-8b88-4753-9077-9d74004d8ec9 | 2026-08-25 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Cardinal Health 107, LLC | ea55ded1-e076-43de-ad3c-c75e7d0a4ebc | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Cardinal Health 107, LLC | fea3ae21-3395-437e-b773-b180e1c98801 | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Coupler LLC | 598f61d7-a665-5d02-e063-6394a90a8905 | 2026-08-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 660YQ98I10 |
| RBUGR smelling salts | AMMONIUM CARBONATE | Nanjing Ludejin Corporation Management Co., Ltd | 42e9f4a6-46c2-8de8-e063-6394a90a8eee | 2026-08-18 | Warnings | NJ5VT0FKLJ |
| Potassium Chloride | POTASSIUM CHLORIDE | Preferred Pharmaceuticals Inc. | 3f19ed0e-6c73-482c-94d6-d3205318fd6f | 2026-08-17 | Warnings, Adverse reactions | 660YQ98I10 |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 660YQ98I10 |
| BM BM165 DROPS | ANGELICA ATRO, BALSAM PER, BARIUM MUR, GRINDELIA, KALI BICH, KALI IOD, KALI MUR, SILPHIUM LAC | BM Private Limited | 590301da-8f93-3b1e-e063-6394a90a1e72 | 2026-08-14 | Warnings | 660YQ98I10 |
| Isopathic Phenolic Rings | HOMEOPATHIC LIQUID | Energetix Corporation | 98a7ca26-ccb7-43c7-bd65-892fcbacc882 | 2026-08-11 | Warnings | C151H8M554 |
| Lipo-Chord | ACETICUM AC, ACETYLSAL AC, ADRENOCORTICOTROPHIN, ALUMINA, ARSENICUM ALB, BORAGO, CEANOTHUS, CHELIDONIUM MAJ, CHIONANTHUS, CHLORAMPHENICOLUM, CHLORPROMAZINUM, CHOLESTERINUM, CORTISONE ACETICUM, DAMIANA, FOLLICULINUM, FUMARICUM AC, KALI IOD, LYCOPODIUM, NAT SULPHURICUM, NUX VOM, OLEUM MORRHUAE, PETROLEUM, PHENACETINUM, PHOSPHORICUM AC, PHOSPHORUS, PLUMB MET, SACCHARUM OFF, SILICEA, TARAXACUM, THYROIDINUM. | Energetix Corporation | 5c83cbd5-46fb-48a0-a739-ff9c81e7129c | 2026-08-11 | Warnings | C151H8M554 |
| Potassium Chloride | POTASSIUM CHLORIDE | Amneal Pharmaceuticals LLC | f9965f73-e189-423f-bd10-c4a0ed12b485 | 2026-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | REMEDYREPACK INC. | 16c775e4-0dd8-4e9f-b2bf-dd2b639374cf | 2026-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | REMEDYREPACK INC. | 7ec22e8e-6643-44fe-804d-ca0b0b266663 | 2026-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 02707146-331f-4511-a187-0152fc8bca85 | 2026-07-24 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.